ALBI Grade, MVI, & Distant Metastases Predict Survival in HCC
HCC survival time is predicted by albumin-bilirubin grade, microvascular invasion, and distant metastases.
Read MoreJun 13, 2024
HCC survival time is predicted by albumin-bilirubin grade, microvascular invasion, and distant metastases.
Read MoreJun 13, 2024
Social determinants of health create barriers that delay access to expensive oral anti-myeloma drugs for people with newly diagnosed multiple myeloma.
Read MoreJun 12, 2024
A quiz based on the latest tardive dyskinesia news and studies.
Read MoreJun 12, 2024
AI and ML advances chronic lymphocytic leukemia therapies.
Read MoreJun 12, 2024
In this medical fiction, Hildi’s misfit cookies spark a unique friendship with chef Mindy, and dramatic kitchen confrontations build a bond beyond baking.
Read MoreJun 11, 2024
Patients with unresectable hepatocellular carcinoma reported better results with nivolumab ipilimumab.
Read MoreJun 11, 2024
Patients with a radical cystectomy did not have fewer complications with an immune-enhancing nutrition drink
Read MoreJun 11, 2024
An analysis of the PSMAfore trial suggests that baseline circulating tumor DNA could have predictive and prognostic value for patients.
Read MoreJun 11, 2024
Patients with non-small cell lung cancer have shown improvements with chemoradiotherapy in a new study.
Read MoreJun 10, 2024
The phase 3 PIVOTAL study has shown that neoadjuvant intralesional daromun can benefit patients with pretreated stage III melanoma.
Read MoreJun 10, 2024
A curated ebook on chronic obstructive pulmonary disease (COPD featuring recent studies, findings, and opinions from thought leaders.
Read MoreJun 7, 2024
A study finds 1 year of avelumab treatment improves distant disease free and overall survival rates in patients with early triple-negative breast cancer.
Read MoreJun 7, 2024
An analysis of the benefits of nivolumab/ipilimumab in MSI-H/dMMR metastatic colorectal cancer on progression free survival rate.
Read MoreJun 7, 2024
Virtual or in person palliative care has shown significant results for patients with non-small cell lung cancer that is incurable.
Read MoreJun 7, 2024
Patients with resectable oesophageal cancer have better results with perioperative chemotherapy and surgery than neoadjuvant chemoradiation and surgery.
Read MoreJun 7, 2024
Metformin, has been found to not benefit patients with low risk prostate cancer.
Read MoreJun 6, 2024
Batiraxcept and paclitaxel as a combination therapy has shown significant results in improving progression free survival and overall rates.
Read MoreJun 6, 2024
A curated ebook on Crohn’s and colitis featuring recent studies, findings, and opinions from thought leaders.
Read MoreJun 6, 2024
Patients with macroscopic stage 3 melanoma have seen improvements with neoadjuvant ipilimumab/nivolumab intake.
Read More